{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T05:40:32Z","timestamp":1756273232939,"version":"3.44.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Immunoglobulin superfamily member 8 (IGSF8) is a membrane protein implicated in crucial biological processes like cell interactions and immune responses. Emerging evidence suggests that IGSF8 plays a significant role in various cancers by influencing tumor progression through regulation of cell proliferation, migration, and apoptosis. Analyzing its expression, mutation status, and clinical correlations across different cancer types through pan-cancer bioinformatics could provide valuable insights into its potential as a biomarker and target for cancer therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we utilized several public databases to investigate the biological role of IGSF8, focusing on its associations with prognosis, tumor heterogeneity, stemness, immune checkpoint genes, and immune cell infiltration across different types of cancer. Additionally, the GDSC and CTRP databases were employed to assess the sensitivity of IGSF8 to small molecule drugs. CCK8 assay and colony formation assay were used to detect its biological effect on cancer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IGSF8 was significantly upregulated in 23 types of cancers and associated with poor prognosis in several cancers, including cell carcinoma and endocervical adenocarcinoma (CESC) and Acute Myeloid Leukemia(LAML). Its high expression was linked to multiple immune regulatory genes and immune checkpoint genes in the tumor microenvironment, with a notable positive correlation with CD276 in most cancers. IGSF8 was also closely associated with multiple indicators of tumor heterogeneity, stemness, as well as significant RNA methylation modifications across various cancers. Drug sensitivity analysis identified BX-795 and tozasertib as potential treatments for tumors with high IGSF8 expression. Knockdown of IGSF8 significantly inhibited the proliferation ability of prostate cancer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings indicated that IGSF8 might be used as a potential prognostic marker and therapeutic target for various cancers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1642193","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T05:18:47Z","timestamp":1756271927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional characterization and clinical significance of IGSF8 in pan-cancer: an integrated bioinformatic and experimental study"],"prefix":"10.3389","volume":"16","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruicheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengxiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luxia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dechao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40779-025-00599-y","article-title":"Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046","volume":"12","author":"Feng","year":"2025","journal-title":"Mil Med Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Mil Med Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: Past, present, and future","author":"Sonkin","year":"2024","journal-title":"Cancer Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2023.04.08","article-title":"Focal ablation therapy presents promising results for selectively localized prostate cancer patients","volume":"35","author":"Feng","year":"2023","journal-title":"Chin J Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101232","article-title":"Novel hormone therapies for advanced prostate cancer: understanding and countering drug resistance","volume":"101232","author":"Wang","year":"2025","journal-title":"J Pharm Anal"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","article-title":"Different strategies for cancer treatment: Targeting cancer cells or their neighbors","volume":"37","author":"Liu","year":"2025","journal-title":"Chin J Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2174\/1874467217666230821142839","article-title":"The targeted therapies for osteosarcoma via six major pathways","volume":"17","author":"Wang","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32598-8","article-title":"Enhancing anti-tumour efficacy with immunotherapy combinations","volume":"397","author":"Meric-Bernstam","year":"2021","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","article-title":"Bispecific antibodies: a mechanistic review of the pipeline","volume":"18","author":"Labrijn","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/ot9.0000000000000039","article-title":"Overview of perspectives on cancer, newer therapies, and future directions","volume":"10","author":"Joshi","year":"2024","journal-title":"Oncol Trans Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01564-7","article-title":"Immunoglobulin superfamily member 8 maintains myeloid leukemia stem cells through inhibition of \u03b2-catenin degradation","volume":"36","author":"Jimbo","year":"2022","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M107338200","article-title":"EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily","volume":"276","author":"Stipp","year":"2001","journal-title":"J Biol Chem"},{"key":"B14","article-title":"EWI2\/PGRL associates with the metastasis suppressor KAI1\/CD82 and inhibits the migration of prostate cancer cells","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02623-8","article-title":"EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate Malignancy","volume":"42","author":"Ding","year":"2023","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2012.05.007","article-title":"IgSF8: a developmentally and functionally regulated cell adhesion molecule in olfactory sensory neuron axons and synapses","volume":"50","author":"Ray","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1044-7431(02)00021-0","article-title":"Genomic organization and embryonic expression of Igsf8, an immunoglobulin superfamily member implicated in development of the nervous system and organ epithelia","volume":"22","author":"Murdoch","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2024.02.118","article-title":"IGSF8 is a potential target for the treatment of Gliomas","volume":"47","author":"Ren","year":"2024","journal-title":"Asian J Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.17","article-title":"EWI-2 negatively regulates TGF-\u03b2 signaling leading to altered melanoma growth and metastasis","volume":"25","author":"Wang","year":"2015","journal-title":"Cell Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"215641","DOI":"10.1016\/j.canlet.2022.215641","article-title":"EWI2 promotes endolysosome-mediated turnover of growth factor receptors and integrins to suppress lung cancer","volume":"536","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"key":"B21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00018-022-04417-9","article-title":"EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation","volume":"79","author":"Fu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12930","article-title":"EWI-2 controls nucleocytoplasmic shuttling of EGFR signaling molecules and miRNA sorting in exosomes to inhibit prostate cancer cell metastasis","volume":"15","author":"Fu","year":"2021","journal-title":"Mol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.03.039","article-title":"IGSF8 is an innate immune checkpoint and cancer immunotherapy target","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"tkae075","DOI":"10.1093\/burnst\/tkae075","article-title":"Basic helix-loop-helix ARNT like 1 regulates the function of immune cells and participates in the development of immune-related diseases","volume":"13","author":"Shao","year":"2025","journal-title":"Burns Trauma"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2023-0002","article-title":"A pan-cancer analysis of the oncogenic role of Golgi transport 1B in human tumors","volume":"11","author":"Tian","year":"2023","journal-title":"J Transl Int Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2024-0023","article-title":"Prognostic prediction of m6A and ferroptosis-associated lncRNAs in liver hepatocellular carcinoma","volume":"12","author":"Gao","year":"2024","journal-title":"J Transl Int Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform","volume":"1","author":"Shen","year":"2022","journal-title":"Imeta"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2023.1126","article-title":"Targeting prolyl 4-hydroxylase subunit beta (P4HB) in cancer: new roads to travel","volume":"15","author":"Feng","year":"2023","journal-title":"Aging Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1572108","article-title":"Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: A large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"B33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0327-7_17","article-title":"EPIC: A tool to estimate the proportions of different cell types from bulk gene expression data","volume":"2120","author":"Racle","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac558","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Brief Bioinform"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1038\/s41467-020-18956-x","article-title":"Synapse type-specific proteomic dissection identifies IgSF8 as a hippocampal CA3 microcircuit organizer","volume":"11","author":"Ap\u00f3stolo","year":"2020","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.04.029","article-title":"Tetraspanin-interacting protein IGSF8 is dispensable for mouse fertility","volume":"98","author":"Inoue","year":"2012","journal-title":"Fertil Steril"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1030536","article-title":"Novel impact of EWI-2, CD9, and CD81 on TGF-\u03b2 signaling in melanoma","volume":"2","author":"Wang","year":"2015","journal-title":"Mol Cell Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"18341","DOI":"10.1038\/s41598-023-44050-5","article-title":"Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer","volume":"13","author":"Trinidad","year":"2023","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3743","article-title":"Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells","volume":"6","author":"Levina","year":"2015","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.1208","article-title":"Common pathogenetic mechanisms underlying aging and tumor and means of interventions","volume":"13","author":"Shen","year":"2022","journal-title":"Aging Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2024.03.09","article-title":"Unraveling links between aging, circadian rhythm and cancer: Insights from evidence-based analysis","volume":"36","author":"Feng","year":"2024","journal-title":"Chin J Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"0612","DOI":"10.34133\/research.0612","article-title":"The common hallmarks and interconnected pathways of aging, circadian rhythms, and cancer: implications for therapeutic strategies","volume":"8","author":"Wang","year":"2025","journal-title":"Research (Wash D C)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2174\/1874467217666230601113430","article-title":"Targeting cellular senescence: A potential therapeutic approach for alzheimer\u2019s disease","volume":"17","author":"Singh","year":"2024","journal-title":"Curr Mol Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2428","article-title":"Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy","volume":"22","author":"Picarda","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","article-title":"New frontiers in immune checkpoint B7-H3 (CD276) research and drug development","volume":"22","author":"Getu","year":"2023","journal-title":"Mol Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.03.005","article-title":"Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature","volume":"31","author":"Seaman","year":"2017","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"113503","DOI":"10.1016\/j.celrep.2023.113503","article-title":"Engineering CD276\/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability","volume":"42","author":"Feng","year":"2023","journal-title":"Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13592","article-title":"Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: \u201cSingle\u201d vision for \u201cheterogeneous\u201d environment","volume":"57","author":"Zhang","year":"2024","journal-title":"Cell Prolif"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.1404","article-title":"Senescent macrophages and the lung cancer microenvironment: A new perspective on tumor immune evasion","author":"Qin","year":"2024","journal-title":"Aging Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0327","article-title":"Chronobiology of the tumor microenvironment: implications for therapeutic strategies and circadian-based interventions","volume":"16","author":"Li","year":"2024","journal-title":"Aging Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2023.03.07","article-title":"Immune evasion and therapeutic opportunities based on natural killer cells","volume":"35","author":"Zhang","year":"2023","journal-title":"Chin J Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90186-i","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0262-1","article-title":"p53: 800 million years of evolution and 40 years of discovery","volume":"20","author":"Levine","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2015.1081168","article-title":"TBK1 inhibitors: a review of patent literature (2011 - 2014)","volume":"25","author":"Yu","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"B62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2174\/1874467215666220803125822","article-title":"Tumor organoid model and its pharmacological applications in tumorigenesis prevention","volume":"16","author":"Qiang","year":"2023","journal-title":"Curr Mol Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.06.022","article-title":"A review on the role of TANK-binding kinase 1 signaling in cancer","volume":"183","author":"Alam","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/1538-7445.AM2018-2162","article-title":"Abstract 2162: Comparing volatile and intravenous anesthetics in a mouse model of breast cancer metastasis","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"166941","DOI":"10.1016\/j.bbadis.2023.166941","article-title":"Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development","volume":"1870","author":"Kang","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"167250","DOI":"10.1016\/j.bbadis.2024.167250","article-title":"hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells","volume":"1870","author":"Lee","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.genrep.2024.102042","article-title":"Genetic expression in cancer research: Challenges and complexity","volume":"37","author":"Liu","year":"2024","journal-title":"Gene Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","article-title":"Technical and biological biases in bulk transcriptomic data mining for cancer research","volume":"16","author":"Liu","year":"2025","journal-title":"J Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40779-024-00526-7","article-title":"The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy","volume":"11","author":"Feng","year":"2024","journal-title":"Mil Med Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13517","article-title":"Single-cell RNA sequencing in osteoarthritis","volume":"56","author":"Gu","year":"2023","journal-title":"Cell Prolif"},{"key":"B72","doi-asserted-by":"publisher","first-page":"0387","DOI":"10.34133\/research.0387","article-title":"Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma","volume":"7","author":"Ye","year":"2024","journal-title":"Research (Wash D C)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1642193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T05:18:48Z","timestamp":1756271928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1642193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":72,"alternative-id":["10.3389\/fimmu.2025.1642193"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1642193","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"article-number":"1642193"}}